Symbols / LITS Stock $1.20 +0.84% Lite Strategy, Inc.

Healthcare • Biotechnology • United States • NCM
LITS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Stock Fundamentals
Scroll to Statements
Market Cap 43.63M Enterprise Value 34.51M Income -39.70M Sales — Book/sh 2.23 Cash/sh 0.24
Dividend Yield — Payout 0.00% Employees 4 IPO — P/E — Forward P/E —
PEG 2.22 P/S — P/B 0.54 P/C — EV/EBITDA -2.14 EV/Sales —
Quick Ratio 8.06 Current Ratio 10.04 Debt/Eq — LT Debt/Eq — EPS (ttm) -1.82 EPS next Y —
EPS Growth — Revenue Growth — Earnings 2026-05-15 ROA -19.00% ROE -76.38% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 36.36M Shs Float 30.51M Short Float 0.29%
Short Ratio 0.33 Short Interest — 52W High 9.00 52W Low 0.95 Beta 0.10 Avg Volume 307.02K
Volume 136.22K Target Price — Recom None Prev Close $1.19 Price $1.20 Change 0.84%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.20
Latest analyst target
3. DCF / Fair value
$-6.08
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.20
Low
—
High
—
Mean
—
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-19 FLYNN JAMES P Director — 70,000 $1.40 $97,699
2025-12-18 SCHORNSTEIN ALEXANDER Beneficial Owner of more than 10% of a Class of Security — 690,611 $1.37 $946,137
2025-11-19 FLYNN JAMES P Director — 12,100 $1.88 $22,777
2025-09-30 FLYNN JAMES P Director — 10,000 $2.54 $25,430
2024-05-17 WOOD STEVEN D Director — 3,100 $3.17 $9,827
2024-05-16 FLYNN JAMES P Director — 7,900 $3.16 $24,981
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
0.00
-100.00%
65.30
+33.76%
48.82
+19.95%
40.70
Operating Revenue
0.00
-100.00%
65.30
+33.76%
48.82
+19.95%
40.70
Cost Of Revenue
—
—
—
0.00
Reconciled Cost Of Revenue
—
—
—
0.00
Gross Profit
—
—
—
40.70
Operating Expense
17.45
-56.20%
39.86
-53.43%
85.58
-26.34%
116.18
Research And Development
3.92
-76.31%
16.56
-68.43%
52.45
-38.76%
85.64
Selling General And Administration
13.53
-41.91%
23.30
-29.69%
33.13
+8.48%
30.54
General And Administrative Expense
13.53
-41.91%
23.30
-29.69%
33.13
+8.48%
30.54
Other Gand A
13.53
-41.91%
23.30
-29.69%
33.13
+8.48%
30.54
Total Expenses
17.45
-56.20%
39.86
-53.43%
85.58
-26.34%
116.18
Operating Income
-17.45
-168.61%
25.44
+169.20%
-36.76
+51.30%
-75.48
Total Operating Income As Reported
-17.45
-220.03%
14.54
+139.55%
-36.76
+51.30%
-75.48
EBITDA
-17.09
-166.17%
25.82
+170.99%
-36.38
+51.60%
-75.16
Normalized EBITDA
-17.59
-147.89%
36.72
+196.69%
-37.98
+60.40%
-95.91
Reconciled Depreciation
0.37
-3.92%
0.38
-0.78%
0.39
+18.40%
0.33
EBIT
-17.45
-168.61%
25.44
+169.20%
-36.76
+51.30%
-75.48
Total Unusual Items
0.50
+104.59%
-10.90
-779.91%
1.60
-92.28%
20.75
Total Unusual Items Excluding Goodwill
0.50
+104.59%
-10.90
-779.91%
1.60
-92.28%
20.75
Special Income Charges
0.50
+104.59%
-10.90
0.00
—
Impairment Of Capital Assets
0.00
-100.00%
10.90
0.00
—
Net Income
-15.95
-189.69%
17.78
+155.84%
-31.84
+41.53%
-54.45
Pretax Income
-15.95
-189.69%
17.78
+155.84%
-31.84
+41.53%
-54.45
Net Non Operating Interest Income Expense
1.03
-68.69%
3.28
-2.03%
3.35
+1077.82%
0.28
Net Interest Income
1.03
-68.69%
3.28
-2.03%
3.35
+1077.82%
0.28
Interest Income Non Operating
1.03
-68.69%
3.28
-2.03%
3.35
+1077.82%
0.28
Interest Income
1.03
-68.69%
3.28
-2.03%
3.35
+1077.82%
0.28
Other Income Expense
0.48
+104.42%
-10.94
-791.97%
1.58
-92.38%
20.75
Other Non Operating Income Expenses
-0.02
+60.98%
-0.04
-86.36%
-0.02
-266.67%
-0.01
Gain On Sale Of Security
—
—
1.60
-92.28%
20.75
Tax Provision
—
—
—
0.00
Tax Rate For Calcs
0.00
-100.00%
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
+100.00%
-2.29
0.00
0.00
Net Income Including Noncontrolling Interests
-15.95
-189.69%
17.78
+155.84%
-31.84
+41.53%
-54.45
Net Income From Continuing Operation Net Minority Interest
-15.95
-189.69%
17.78
+155.84%
-31.84
+41.53%
-54.45
Net Income From Continuing And Discontinued Operation
-15.95
-189.69%
17.78
+155.84%
-31.84
+41.53%
-54.45
Net Income Continuous Operations
-15.95
-189.69%
17.78
+155.84%
-31.84
+41.53%
-54.45
Normalized Income
-16.45
-162.32%
26.39
+178.91%
-33.44
+55.53%
-75.21
Net Income Common Stockholders
-15.95
-189.69%
17.78
+155.84%
-31.84
+41.53%
-54.45
Diluted EPS
-2.39
-189.51%
2.67
+155.86%
-4.78
+52.15%
-9.99
Basic EPS
-2.39
-189.51%
2.67
+155.86%
-4.78
+45.37%
-8.75
Basic Average Shares
6.66
+0.00%
6.66
+0.00%
6.66
+7.05%
6.22
Diluted Average Shares
6.66
+0.00%
6.66
+0.00%
6.66
+6.49%
6.26
Diluted NI Availto Com Stockholders
-15.95
-189.69%
17.78
+155.84%
-31.84
+49.06%
-62.50
Average Dilution Earnings
—
—
0.00
+100.00%
-8.05
Gain On Sale Of PPE
0.50
0.00
—
—
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Assets
18.29
-55.81%
41.38
-65.75%
120.81
-32.07%
177.84
Current Assets
18.29
-55.15%
40.77
-62.09%
107.53
-35.66%
167.13
Cash Cash Equivalents And Short Term Investments
18.01
-53.03%
38.34
-61.92%
100.69
-34.30%
153.25
Cash And Cash Equivalents
18.01
+386.13%
3.71
-78.08%
16.91
+7.41%
15.74
Other Short Term Investments
0.00
-100.00%
34.64
-58.66%
83.79
-39.07%
137.51
Receivables
—
0.00
-100.00%
0.09
-99.15%
10.04
Accounts Receivable
—
—
0.00
0.00
Other Receivables
—
—
0.09
-99.15%
10.04
Taxes Receivable
—
—
—
—
Prepaid Assets
0.00
-100.00%
1.05
-77.17%
4.60
+20.08%
3.83
Other Current Assets
0.27
-80.06%
1.37
-36.12%
2.15
-43.84%
3.83
Total Non Current Assets
0.00
-100.00%
0.61
-95.44%
13.28
+23.96%
10.71
Net PPE
0.00
-100.00%
0.61
-95.44%
13.28
+23.96%
10.71
Gross PPE
0.00
-100.00%
2.37
-83.44%
14.31
+25.99%
11.36
Accumulated Depreciation
—
-1.76
-70.60%
-1.03
-59.57%
-0.65
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
0.00
-100.00%
0.21
-98.21%
11.97
+32.23%
9.05
Machinery Furniture Equipment
—
1.00
+0.00%
1.00
-20.26%
1.25
Other Properties
—
0.19
-50.00%
0.37
-95.87%
9.05
Leases
—
0.97
+0.00%
0.97
-8.06%
1.05
Goodwill And Other Intangible Assets
—
—
—
—
Total Liabilities Net Minority Interest
1.35
-83.79%
8.36
-91.31%
96.19
-23.31%
125.43
Current Liabilities
1.35
-83.79%
8.36
-58.92%
20.34
-16.79%
24.44
Payables And Accrued Expenses
0.48
-91.31%
5.53
-51.48%
11.41
-20.75%
14.39
Payables
0.18
-94.44%
3.17
-48.35%
6.13
-22.53%
7.92
Accounts Payable
0.18
-94.44%
3.17
-48.35%
6.13
-22.53%
7.92
Current Accrued Expenses
0.30
-87.11%
2.37
-55.12%
5.27
-18.57%
6.47
Pensionand Other Post Retirement Benefit Plans Current
0.87
-69.05%
2.82
-60.76%
7.19
+65.42%
4.35
Current Debt And Capital Lease Obligation
—
—
1.43
+63.95%
0.87
Current Capital Lease Obligation
—
0.00
-100.00%
1.43
+63.95%
0.87
Current Deferred Liabilities
—
0.00
-100.00%
0.32
-93.44%
4.83
Current Deferred Revenue
—
0.00
-100.00%
0.32
-93.44%
4.83
Total Non Current Liabilities Net Minority Interest
0.00
0.00
-100.00%
75.84
-24.89%
100.98
Long Term Debt And Capital Lease Obligation
—
0.00
-100.00%
11.30
+28.83%
8.77
Long Term Capital Lease Obligation
—
0.00
-100.00%
11.30
+28.83%
8.77
Non Current Deferred Liabilities
—
0.00
-100.00%
64.55
-28.77%
90.61
Non Current Deferred Revenue
—
0.00
-100.00%
64.55
-28.77%
90.61
Stockholders Equity
16.93
-48.73%
33.02
+34.10%
24.62
-53.02%
52.41
Common Stock Equity
16.93
-48.73%
33.02
+34.10%
24.62
-53.02%
52.41
Capital Stock
0.00
0.00
0.00
0.00
Common Stock
0.00
0.00
0.00
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
6.66
+0.00%
6.66
0.00%
6.66
+0.08%
6.66
Ordinary Shares Number
6.66
+0.00%
6.66
0.00%
6.66
+0.08%
6.66
Additional Paid In Capital
421.10
-0.03%
421.24
-2.18%
430.62
+0.95%
426.57
Retained Earnings
-404.16
-4.11%
-388.22
+4.38%
-406.00
-8.51%
-374.16
Total Equity Gross Minority Interest
16.93
-48.73%
33.02
+34.10%
24.62
-53.02%
52.41
Total Capitalization
16.93
-48.73%
33.02
+34.10%
24.62
-53.02%
52.41
Working Capital
16.93
-47.77%
32.41
-62.82%
87.19
-38.89%
142.68
Invested Capital
16.93
-48.73%
33.02
+34.10%
24.62
-53.02%
52.41
Total Debt
—
0.00
-100.00%
12.73
+32.01%
9.64
Capital Lease Obligations
—
0.00
-100.00%
12.73
+32.01%
9.64
Net Tangible Assets
16.93
-48.73%
33.02
+34.10%
24.62
-53.02%
52.41
Tangible Book Value
16.93
-48.73%
33.02
+34.10%
24.62
-53.02%
52.41
Derivative Product Liabilities
—
—
0.00
-100.00%
1.60
Preferred Shares Number
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Cash Flow
-20.84
+58.70%
-50.47
+3.83%
-52.48
-7.67%
-48.75
Cash Flow From Continuing Operating Activities
-20.84
+58.70%
-50.47
+3.83%
-52.48
-7.67%
-48.75
Net Income From Continuing Operations
-15.95
-189.69%
17.78
+155.84%
-31.84
+41.53%
-54.45
Depreciation Amortization Depletion
0.37
-3.92%
0.38
-0.78%
0.39
+18.40%
0.33
Depreciation
0.37
-3.92%
0.38
-0.78%
0.39
+18.40%
0.33
Depreciation And Amortization
0.37
-3.92%
0.38
-0.78%
0.39
+18.40%
0.33
Other Non Cash Items
0.21
-91.20%
2.43
+70.26%
1.43
+57.21%
0.91
Stock Based Compensation
-0.14
-106.32%
2.28
-36.53%
3.59
-57.02%
8.35
Asset Impairment Charge
0.00
-100.00%
10.90
0.00
0.00
Operating Gains Losses
-0.49
-1618.75%
0.03
+102.90%
-1.10
+94.68%
-20.75
Gain Loss On Investment Securities
-0.50
—
-1.10
+94.68%
-20.75
Gain Loss On Sale Of PPE
0.01
-56.25%
0.03
0.00
—
Change In Working Capital
-4.85
+94.24%
-84.28
-237.82%
-24.95
-247.83%
16.88
Change In Receivables
0.00
-100.00%
0.09
-99.15%
9.96
+504.51%
-2.46
Change In Prepaid Assets
2.15
-52.58%
4.53
+255.27%
-2.92
-13804.76%
-0.02
Change In Payables And Accrued Expense
-7.00
+32.82%
-10.42
-7187.41%
-0.14
-103.59%
3.98
Change In Accrued Expense
-4.01
+44.89%
-7.27
-543.27%
1.64
-32.13%
2.42
Change In Payable
-2.99
+4.93%
-3.15
-76.40%
-1.78
-214.14%
1.56
Change In Account Payable
-2.99
+4.93%
-3.15
-76.40%
-1.78
-214.14%
1.56
Change In Other Working Capital
—
-64.86
-112.09%
-30.58
-288.52%
16.22
Change In Other Current Liabilities
0.00
+100.00%
-13.61
-979.46%
-1.26
-49.23%
-0.84
Investing Cash Flow
35.15
-28.47%
49.14
-8.47%
53.69
+679.02%
6.89
Cash Flow From Continuing Investing Activities
35.15
-28.47%
49.14
-8.47%
53.69
+679.02%
6.89
Net PPE Purchase And Sale
0.01
+242.86%
-0.01
+80.00%
-0.04
+92.69%
-0.48
Purchase Of PPE
0.00
+100.00%
-0.01
+80.00%
-0.04
+92.69%
-0.48
Sale Of PPE
0.01
0.00
—
—
Capital Expenditure
—
-0.01
+80.00%
-0.04
+92.69%
-0.48
Net Investment Purchase And Sale
35.14
-28.50%
49.15
-8.52%
53.73
+628.87%
7.37
Purchase Of Investment
0.00
+100.00%
-58.23
+42.78%
-101.76
+62.68%
-272.65
Sale Of Investment
35.14
-67.27%
107.38
-30.94%
155.49
-44.47%
280.02
Financing Cash Flow
0.00
+100.00%
-11.87
-29570.00%
-0.04
-100.08%
49.05
Cash Flow From Continuing Financing Activities
0.00
+100.00%
-11.87
-29570.00%
-0.04
-100.08%
49.05
Net Common Stock Issuance
—
—
0.00
-100.00%
52.33
Common Stock Dividend Paid
0.00
+100.00%
-11.66
0.00
—
Cash Dividends Paid
0.00
+100.00%
-11.66
0.00
—
Proceeds From Stock Option Exercised
—
—
0.00
-100.00%
0.57
Net Other Financing Charges
—
-0.21
-420.00%
-0.04
+98.96%
-3.85
Changes In Cash
14.31
+208.37%
-13.20
-1232.16%
1.17
-83.80%
7.20
Beginning Cash Position
3.71
-78.08%
16.91
+7.41%
15.74
+84.24%
8.54
End Cash Position
18.01
+386.13%
3.71
-78.08%
16.91
+7.41%
15.74
Free Cash Flow
-20.84
+58.71%
-50.48
+3.88%
-52.52
-6.69%
-49.23
Income Tax Paid Supplemental Data
—
—
—
0.00
Common Stock Issuance
—
—
0.00
-100.00%
52.33
Issuance Of Capital Stock
—
—
0.00
-100.00%
52.33
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category